Cagrilintide – 5 mg
Cagrilintide – 5 mg Cagrilintide (5 mg) is an investigational, long-acting acylated amylin analogue designed as a once-weekly subcutaneous injection for weight management. It acts as a nonselective amylin and calcitonin receptor agonist, reducing food intake and promoting weight loss. Studies show it is well-tolerated, and it is being developed both as a monotherapy and in combination with semaglutide (CagriSema).
Research Use Only Disclaimer
FOR RESEARCH USE ONLY This product is not intended for human or animal use.Not for medical, diagnostic, therapeutic, metabolic, weight-related, or consumption purposes.No dosage, administration, or biological outcome claims are made or implied.Use is restricted to qualified laboratory research environments only.
❓Frequently Asked Questions
Is cagrilintide approved for medical or dietary use?
No. This peptide is supplied strictly for laboratory research purposes.
Does this product include a Certificate of Analysis (COA)?
Yes. Every batch includes a third-party verified COA.
Why is this peptide supplied in a 5 mg format?
This quantity supports analytical precision, stability studies, and reference evaluation, not consumption.
Can this compound be used in humans or animals?
No. It is not approved for use in living systems.
How is this product classified?
It is classified solely as a research peptide, not a drug, supplement, or therapeutic agent. 🔗 Internal Linking Suggestions (Shopify) Use Shopify’s internal linking tools t